The direct correlation between earnings reports and stock price movements is well-documented. In this case, The Oncology Institute's worse-than-expected Q4 GAAP EPS results likely led to a loss of investor confidence, resulting in a decrease in stock price. Given the specificity of the news to TOI's financial performance, its relevance and importance to investors are high. The confidence in this analysis is based on the typical market response to earnings misses.